Vortioxetine (Brintellix)
Is It Right for You?
A complete guide to Vortioxetine (Brintellix) — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Vortioxetine (Brintellix)?
Vortioxetine, marketed as Brintellix, is a multimodal antidepressant with a unique and complex pharmacological profile that distinguishes it from conventional antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). It is available in tablets of 5 mg, 10 mg, 15 mg, and 20 mg for once-daily dosing.
Unlike SSRIs, which act solely through serotonin transporter (SERT) inhibition, vortioxetine combines SERT inhibition with direct agonist, partial agonist, and antagonist activity at multiple serotonin receptor subtypes. This multimodal mechanism is associated not only with improvements in mood and anxiety but also with clinically meaningful benefits on cognitive function — including concentration, memory, and processing speed — which are frequently impaired in major depressive disorder (MDD) but poorly addressed by conventional antidepressants.
Vortioxetine is a prescription-only medication in the UK. A clinician must assess your psychiatric history, current medications, and medical history before prescribing.
What Conditions Is Vortioxetine Used For?
Vortioxetine is indicated for:
licensed for the treatment of MDD in adult patients; particularly considered where cognitive symptoms (brain fog, poor concentration, memory difficulties) are a prominent feature of the depressive episode
continued use after remission reduces the risk of depressive relapse; treatment duration is typically at least 6 months following full responsd
used off-label in clinical practice for anxiety symptoms, though its primary licence is for MDD
Full antidepressant effects typically take 4–6 weeks to manifest. It is important not to discontinue vortioxetine prematurely due to perceived lack of early response. Stopping without tapering may cause discontinuation symptoms, though these are generally milder than with SSRIs and SNRIs.
How Does Vortioxetine Work?
Vortioxetine's multimodal mechanism sets it apart from all other licensed antidepressants:
Serotonin transporter (SERT) inhibition like SSRIs, vortioxetine blocks SERT, preventing the reuptake of serotonin from the synaptic cleft back into the presynaptic neuron. This increases available serotonin at postsynaptic receptors, contributing to antidepressant and anxiolytic effects.
5-HT1A receptor agonism vortioxetine is a full agonist at 5-HT1A autoreceptors, which modulates serotonin release and contributes to anxiolytic effects. This activity also partially counteracts some SERT-related side effects.
5-HT1B receptor partial agonism modulates serotonin and other neurotransmitter release (including dopamine and norepinephrine) in key limbic and prefrontal circuits involved in mood and cognition.
5-HT3 receptor antagonism antagonism of 5-HT3 receptors (also involved in vomiting pathways and cognition modulation) is associated with procognitive effects and reduced nausea — contrasting with the nausea-inducing effect of purely SERT-inhibiting antidepressants.
5-HT7 receptor antagonism 5-HT7 receptor blockade contributes to the distinctive cognitive and antidepressant benefits of vortioxetine, particularly improvements in executive function and processing speed.
This receptor diversity produces modulation of multiple neurotransmitter systems — including serotonin, norepinephrine, dopamine, histamine, glutamate, and GABA — in cortical and subcortical circuits relevant to mood, anxiety, and cognition.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Can be taken with or without food. Food does not significantly affect absorption.
Take at the same time each day. Once-daily dosing at a consistent time helps maintain stable plasma levels.
Allow 4–6 weeks before assessing full response. Antidepressant effects build gradually. Partial response at 4 weeks often predicts full response with continued treatment.
Do not stop suddenly. Although vortioxetine has a milder discontinuation profile than many other antidepressants, a gradual taper is recommended when stopping, particularly from higher doses.
Inform your clinician of all medications. Vortioxetine interacts with serotonergic drugs and CYP2D6 inhibitors; a complete medication review is essential before prescribing.
Side Effects of Vortioxetine
Most side effects are mild and resolve on their own. Serious side effects are rare but require immediate medical attention.
- Nausea --- the most frequently reported side effect, typically dose-related and most prominent in the first 1–2 weeks; usually resolves spontaneously
- Diarrhoea or constipation
- Vomiting (less common than nausea)
- Dizziness
- Pruritus (itching) and skin reactions --- more common than with SSRIs
- Dry mouth
- Hyperhidrosis (abnormal sweating)
- Vivid dreams or sleep disturbances
- Serotonin syndrome --- potentially life-threatening; presents with agitation, tremor, myoclonus, hyperthermia, tachycardia, and diaphoresis; risk greatly increased by concurrent serotonergic drugs
- Suicidal ideation --- as with all antidepressants, there is an increased risk of emergent suicidal thoughts, particularly in patients under 25 years of age, in the early weeks of treatment or following dose changes; close monitoring is essential
- Hyponatraemia --- low sodium (particularly in elderly patients, or those on diuretics); presents with confusion, headache, weakness, or seizures
- Severe bleeding --- serotonergic antidepressants impair platelet aggregation; increased bleeding risk, particularly GI bleeding; risk elevated with concurrent NSAIDs or anticoagulants
- Mania or hypomania --- may be unmasked in patients with bipolar disorder; vortioxetine should not be used without a mood stabiliser in bipolar patients
- Severe hypersensitivity reactions --- angioedema or anaphylaxis; rare
All antidepressants carry a class-level warning regarding increased risk of suicidal thinking, particularly in patients under 25 years of age during the first weeks of treatment or following any dose change. Patients, families, and carers must be informed of this risk and instructed to seek urgent help if concerning thoughts emerge. Clinical review within the first 2 weeks of initiating treatment is recommended.
Drug Interactions
Vortioxetine may interact with other medications, including serotonergic drugs and CYP2D6 inhibitors. Always inform your clinician about all medications you are taking.
significantly increase vortioxetine plasma levels; dose reduction of vortioxetine to half the current dose is recommended.
substantially reduce vortioxetine plasma levels; dose increase may be required; clinician review essential.
including SSRIs, SNRIs, tramadol, triptans, St John's Wort, and fentanyl; increased risk of serotonin syndrome; use with extreme caution if combination is clinically necessary.
increased risk of bleeding due to additive antiplatelet effects; monitor for signs of GI bleeding.
Important Warnings
Serotonin syndrome is a serious and potentially fatal condition resulting from excess serotonergic activity. It is most likely when vortioxetine is combined with other serotonergic medications. Symptoms include agitation, tremor, muscle twitching, diarrhoea, high temperature, and rapid heart rate. Seek emergency care immediately if these symptoms develop.
As with all antidepressants, patients — particularly those aged under 25 — must be closely monitored for emergence or worsening of suicidal ideation in the first weeks of treatment and following any dose change. Carers and family members should be instructed to watch for concerning behavioural changes.
Vortioxetine monotherapy can precipitate mania or hypomania in patients with undiagnosed or undertreated bipolar disorder. Screen for bipolar features before initiating antidepressant therapy.
Serotonergic antidepressants are associated with SIADH-related hyponatraemia, particularly in elderly patients or those taking diuretics. Baseline sodium should be considered in at-risk patients, and new neurological symptoms investigated promptly.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Vortioxetine FAQs
Unlike standard SSRIs or SNRIs, vortioxetine acts on multiple serotonin receptor subtypes in addition to blocking the serotonin transporter. This multimodal profile is associated with benefits on cognitive symptoms — including concentration, memory, and mental sharpness — that conventional antidepressants address less effectively.
Cognitive symptoms are a core feature of depression and are often the most disabling aspect. Clinical trials demonstrate meaningful improvements in processing speed, executive function, and memory with vortioxetine compared to placebo, and in some studies compared to other antidepressants. Results vary between individuals.
Most patients notice some improvement within 2–4 weeks, with full antidepressant benefit typically emerging over 4–6 weeks of regular treatment. Cognitive benefits may take a similar or slightly longer time to become fully apparent.
Vortioxetine has a lower reported rate of sexual dysfunction compared to SSRIs in clinical trials — a clinically important advantage for many patients. However, sexual side effects (including reduced libido and delayed orgasm) can still occur; report these to your clinician if they arise.
Clinical studies suggest vortioxetine does not significantly impair psychomotor function when combined with alcohol at moderate doses. However, alcohol is a central nervous system depressant and can worsen depression; it is generally inadvisable to consume alcohol regularly during treatment for depression regardless of medication.